KEAP1 and metabolic dysfunction-associated steatotic liver disease: p62 expression was elevated in MASLD, keap1 was sequestered by p62 and no longer binds to nrf2, and the inhibitory effect of keap1 on nrf2 was reduced leading to increased nrf2 signaling.